Abstract
Bax, one of thebcl-2 family genes, is expressed in a number of untransformed cell lines and various breast tissues, whereas only weak or no expression has been detected in breast cancer cell lines and malignant breast tissue. Human breast cancer MCF-7 cells, which have a weakbax gene expression, were stably transfected withpCX2neo bax, encoding humanbax; and two unique clones,MCF-7/bax-1 andMCF-7/bax-2, that expressed different levels ofbax were generated. Sensitivity to cisplatin (CDDP) and etoposide (VP-16) was examined and each stable transfectant was more sensitive to these agents than the parental MCF-7 cells. The degree of enhancement in sensitivity to these anticancer agents was dependent on the expression level ofbax. The enzyme-linked immunosorbent assay (ELISA), which quantifies DNA damage, demonstrated that this sensitization was due to apoptosis. Thus, we suggest that exogenousbax-α overexpression may be one of the factors determining cellular chemosensitivity in MCF-7 breast cancer cells and that it could be applied therapeutically to enhance chemosensitivity in breast cancer cells.
This is a preview of subscription content, log in via an institution to check access.
References
Chiou SK, Rao L, White E (1994) Bcl-2 blocks p53 dependent apoptosis. Mol Cell Biol 14:2556–2563
Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957–967
Nunez G, Clarke MF (1994) The Bcl-2 fmaily of proteins: regulators of cell death and survival. Trends Cell Biol 4:399–403
Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di-Fronzo G, Rilke F, Veronesi U (1994) The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer in patients. 5 J Natl Cancer Inst 86:499–504
Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, Castle VP (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54:3253–3259
Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J (1993) bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res 53:4251–4256
Korsmeryer SJ (1992) Bcl-2: an antidote to programmed cell death. Cancer Surv 15:105–118
Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerize in vivo with a conserved homologue, bax, that accelerates programmed cell death. Cell 74:609–619
Bargou R, Daniel PT, Mapara MY, Bommert K, Wagener C, Kallinich B, Royer HD, Doreken B (1995) Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-α expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 60:854–859
Zhan Q, Fan S, Bae I, Guilouf C, Liebermann DA, O'connor PM, Fornace AJ Jr (1994) Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9:3743–3751
Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597–608
Sumantran VN, Ealovega MW, Nunez G, Clarke MF, Wicha MS (1995) Overexpression of bcl-Xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 55:2507–2510
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sakakura, C., Sweeney, E.A., Shirahama, T. et al. Overexpression ofBax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide. Surg Today 27, 676–679 (1997). https://doi.org/10.1007/BF02388231
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02388231